Skip to main content

Tipp

Weitere Artikel dieser Ausgabe durch Wischen aufrufen

Erschienen in: memo - Magazine of European Medical Oncology 3/2022

01.09.2022 | editorial

Neoadjuvant treatment for solid tumors—the earlier, the better

verfasst von: Univ.-Prof. Dr. Rupert Bartsch, Prof. Dr. Wolfgang Hilbe

Erschienen in: memo - Magazine of European Medical Oncology | Ausgabe 3/2022

Einloggen, um Zugang zu erhalten

Excerpt

Administering adjuvant systemic treatment following local therapy aiming to reduce recurrence rates and mortality is a standard approach in many common malignancies such as breast, colorectal, or lung cancer. Of note, administering systemic treatment already before surgery offers potential additional advantages such as downstaging and downsizing of the primary tumor and regional lymph nodes, in vivo sensitivity testing, earliest possible treatment of potential micrometastatic disease, and response-adapted tailoring of further postoperative therapy. …
Metadaten
Titel
Neoadjuvant treatment for solid tumors—the earlier, the better
verfasst von
Univ.-Prof. Dr. Rupert Bartsch
Prof. Dr. Wolfgang Hilbe
Publikationsdatum
01.09.2022
Verlag
Springer Vienna
Erschienen in
memo - Magazine of European Medical Oncology / Ausgabe 3/2022
Print ISSN: 1865-5041
Elektronische ISSN: 1865-5076
DOI
https://doi.org/10.1007/s12254-022-00835-4

Weitere Artikel der Ausgabe 3/2022

memo - Magazine of European Medical Oncology 3/2022 Zur Ausgabe